SpIntellx is a Pennsylvania-based AI platform that offers drug discovery, clinical trial optimization, workflow management, and analytics for the healthcare sector. SpIntellx was founded in 2017. SpIntellx's headquarters is located in Pittsburgh, Penn... SpIntellx's CEO, B. Dusty Majumdar, currently has an approval
rating of 86%. SpIntellx's primary competitors are Paige, PreciseDx & PathAI.
There have been no acquisitions found related to SpIntellx
Recent investment data cannot be found related to SpIntellx